Introduzione del consenso informato dinamico per i pazienti rari - Progetto “Biobanks, registries and national health records: modelling a networking strategy to foster research & development and to support the secondary use of data and samples of rare...

Title

Code

Consenso Dinamico

Type

Osservazionale

Start Year

2024

Status

In Corso

Principal Investigator

051-6366519, 051-6366681

luca.sangiorgi@ior.it

Sangiorgi Luca, MD

Director

Rare skeletal disorders

Operational unit that carry out the study

complex unit

Malattie rare scheletriche

Director

Sangiorgi Luca, MD

Go to the details >>

Documents and Videos attachament

Attachment

Nulla osta alla conduzione dello studio prot. Consenso Dinamico

Wednesday 25 September 2024, 16:21

PG0013885_2024_Stampa_unica.pdf

You might also be interested in

Clinical Trial

A Phase 2/3, Randomized, Multicenter Study to Evaluate AL102 in Patients with Progressing Desmoid Tumors

Clinical Trial

Phase study 1/2 to evaluate palbociclib (IBRANCE®) in combination with irinotecan and temozolomide or in combination with topotecan and cyclophosphamide in pediatric patients with recurrent orrefractory solid tumors

IRCCS

ISTITUTO ORTOPEDICO RIZZOLI

Introduzione del consenso informato dinamico per i pazienti rari - Progetto “Biobanks, registries and national health records: modelling a networking strategy to foster research & development and to support the secondary use of data and samples of rare...

Principal Investigator

Operational unit that carry out the study

Documents and Videos attachament

You might also be interested in

Sito Web Istituto Ortopedico Rizzoli

Introduzione del consenso informato dinamico per i pazienti rari - Progetto “Biobanks, registries and national health records: modelling a networking strategy to foster research & development and to support the secondary use of data and samples of rare...

Principal Investigator

Operational unit that carry out the study

Documents and Videos attachament

You might also be interested in